Vivus Inc (VVUS):企業の財務・戦略的SWOT分析

◆英語タイトル:Vivus Inc (VVUS) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1653
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Vivus Inc (VVUS) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Vivus Inc (Vivus) is a biopharmaceutical company that develops and commercializes next-generation therapeutics for addressing unmet medical needs of obesity, sleep apnea, diabetes, and sexual health. The company markets phentermine and topiramate extended-release capsules for the chronic weight management in adult patients; avanafil, an oral phosphodiesterase type 5, for erectile dysfunction; and pancrelipase microtablets for exocrine pancreatic insufficiency. It is investigating its pipeline products for the treatment of obstructive sleep apnea, nonalcoholic steatohepatitis, diabetes, and pulmonary arterial hypertension. Vivus works in partnership with pharmaceutical companies to advance of its product and pipeline portfolio. The company also has direct operations through its subsidiaries in Canada and the Netherlands. Vivus is headquartered in Campbell, California, the US.

Vivus Inc Key Recent Developments

Apr 03,2020 VitalTech partners with VIVUS Pharmaceuticals to accelerate launch of telehealth and remote patient monitoring modules
Apr 01,2020 VIVUS announces $11.55 million registered direct offering priced at-the-market under Nasdaq Rules
Mar 31,2020 VIVUS accelerates the launch of telemedicine and remote monitoring modules to facilitate effective patient care during “social distancing”
Mar 03,2020 VIVUS reports fourth quarter and full year 2019 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Vivus Inc – Key Facts
Vivus Inc – Key Employees
Vivus Inc – Key Employee Biographies
Vivus Inc – Major Products and Services
Vivus Inc – History
Vivus Inc – Company Statement
Vivus Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Vivus Inc – Business Description
Product Category: License and Milestone Revenue
Performance
Product Category: Pancreaze/ Pancreaze MT (Net Product and Royalty Revenue)
Performance
Product Category: Qsymia (Net Product and Supply Revenue)
Performance
Product Category: Stendra/Spedra (Supply and Royalty Revenue)
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: The US
Performance
Vivus Inc – Corporate Strategy
Vivus Inc – SWOT Analysis
SWOT Analysis – Overview
Vivus Inc – Strengths
Vivus Inc – Weaknesses
Vivus Inc – Opportunities
Vivus Inc – Threats
Vivus Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Vivus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Vivus Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Vivus Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 03, 2020: VitalTech partners with VIVUS Pharmaceuticals to accelerate launch of telehealth and remote patient monitoring modules
Apr 01, 2020: VIVUS announces $11.55 million registered direct offering priced at-the-market under Nasdaq Rules
Mar 31, 2020: VIVUS accelerates the launch of telemedicine and remote monitoring modules to facilitate effective patient care during “social distancing”
Mar 03, 2020: VIVUS reports fourth quarter and full year 2019 financial results
Nov 05, 2019: VIVUS reports third quarter 2019 financial results
Oct 28, 2019: VIVUS announces departures of Eric W. Roberts and Allan L. Shaw from Board of Directors
Aug 06, 2019: VIVUS reports second quarter 2019 financial results
Apr 30, 2019: VIVUS Reports First Quarter 2019 Financial Results
Feb 26, 2019: VIVUS announces fourth quarter 2018 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Vivus Inc, Key Facts
Vivus Inc, Key Employees
Vivus Inc, Key Employee Biographies
Vivus Inc, Major Products and Services
Vivus Inc, History
Vivus Inc, Subsidiaries
Vivus Inc, Key Competitors
Vivus Inc, Ratios based on current share price
Vivus Inc, Annual Ratios
Vivus Inc, Annual Ratios (Cont...1)
Vivus Inc, Annual Ratios (Cont...2)
Vivus Inc, Interim Ratios
Vivus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Vivus Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Vivus Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Vivus Inc, Performance Chart (2015 - 2019)
Vivus Inc, Ratio Charts
Vivus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Vivus Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Vivus Inc (VVUS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Michigan Public Power Agency:企業の戦略的SWOT分析
    Michigan Public Power Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Pharma Two B Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharma Two B Ltd (Pharma Two) is a drug development company that develops and manufactures drugs for the treatment of Parkinson's disease and cancer. The company provides combination products in preclinical state and generic products including P2B 005, P2B 006, P2B 007, P2B 008 and P2B 009, …
  • Envision Healthcare Corp:戦略・SWOT・企業財務分析
    Envision Healthcare Corp - Strategy, SWOT and Corporate Finance Report Summary Envision Healthcare Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • BEKB | BCBE Private Banking:企業の戦略・SWOT・財務分析
    BEKB | BCBE Private Banking - Strategy, SWOT and Corporate Finance Report Summary BEKB | BCBE Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Altadis USA Inc:企業の戦略・SWOT・財務情報
    Altadis USA Inc - Strategy, SWOT and Corporate Finance Report Summary Altadis USA Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • LM Wind Power Holding AS:企業の戦略的SWOT分析
    LM Wind Power Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • VentriPoint Diagnostics Ltd:医療機器:M&Aディール及び事業提携情報
    Summary VentriPoint Diagnostics Ltd (Ventripoint) is a medical device company that manufactures and distributes diagnostic tools and monitoring devices for patients with heart diseases. The company provides ventripoint diagnostic system, which is a cardiovascular monitoring and measurement device. I …
  • Orascom Development Egypt Sae:企業の戦略・SWOT・財務分析
    Orascom Development Egypt Sae - Strategy, SWOT and Corporate Finance Report Summary Orascom Development Egypt Sae - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Virgin Atlantic Airways Ltd:企業の戦略・SWOT・財務分析
    Virgin Atlantic Airways Ltd - Strategy, SWOT and Corporate Finance Report Summary Virgin Atlantic Airways Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Corium International Inc (CORI):企業の財務・戦略的SWOT分析
    Summary Corium International Inc (Corium) is a commercial-stage biopharmaceutical company that produces and develops central nervous system pharmaceutical products. The company develops transdermal healthcare products with the help of Corplex technology platform using small molecules. Its products i …
  • EWE AG:電力:M&Aディール及び事業提携情報
    Summary EWE AG (EWE) operates in energy, telecommunication and information technology businesses. The company is involved in generation and transmission of energy, gas storage and waste water treatment. EWE plans, builds and operates renewable power generation plants globally. The company operates c …
  • Bayerische Patentallianz GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Bayerische Patentallianz GmbH (Bayerische Patentallianz) is a central patent and marketing agency that evaluates and markets the inventions, protecting, marketing and achieving financial benefits. The agency provides support and consulting services to small and medium businesses and free inv …
  • Fred’s, Inc.:戦略・SWOT・企業財務分析
    Fred's, Inc. - Strategy, SWOT and Corporate Finance Report Summary Fred's, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Secure Trust Bank Plc:企業の戦略・SWOT・財務情報
    Secure Trust Bank Plc - Strategy, SWOT and Corporate Finance Report Summary Secure Trust Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Avenue Therapeutics Inc (ATXI):製薬・医療:M&Aディール及び事業提携情報
    Summary Avenue Therapeutics Inc (Avenue Therapeutics), a subsidiary of Fortress Biotech Inc, is a specialty pharmaceutical company that focuses on the development and commercialization of an intravenous (IV) tramadol for the management of severe postoperative pain in adults. The company’s IV Tramado …
  • vTv Therapeutics Inc (VTVT)-製薬・医療分野:企業M&A・提携分析
    Summary vTv Therapeutics Inc (vTv), formerly TransTech Inc is a clinical stage pharmaceutical company that discovers, develops and commercializes small molecule drug candidates. The company’s pipeline products include azeliragon, TTP399, TTP273, HPP593, HPP737, HPP971 and hexokinase II inhibitors. I …
  • Standard Life plc:企業のM&A・事業提携・投資動向
    Standard Life plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Standard Life plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Nova Eye Medical Ltd (EYE):企業の財務・戦略的SWOT分析
    Nova Eye Medical Ltd (EYE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Asahi Kasei Pharma Corp-製薬・医療分野:企業M&A・提携分析
    Summary Asahi Kasei Pharma Corp (Asahi Kasei Pharma), a subsidiary of Asahi Kasei Corp, discovers, develops, manufactures, and markets pharmaceuticals and diagnostic products. The company's portfolio encompasses prescription drugs, diagnostic reagents, and enzymes for diagnostic reagents. Its prescr …
  • Abaxis Inc:企業の戦略的SWOT分析
    Abaxis Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆